ACTAVIS
Dead / Abandoned — Abandoned — no statement of use filed (as of 12 Feb 2018)
What this means for you
This application is over — abandoned 12 Feb 2018. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85773902
- Mark type
- Design + words
- Filed
- 07 Nov 2012
- Published for opposition
- 06 Aug 2013
- Abandoned
- 12 Feb 2018
- Attorney of record
- Gabrielle S. Roth
Goods and services
- Class 001 — Chemicals: Chemicals used in industry and science, namely, active chemical ingredients for use in the manufacture of pharmaceuticals, chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for scientific purposes; chemical preparations for use in industry
- Class 003 — Cosmetics and cleaning preparations: Soaps; Perfumery; Essential Oils; Cosmetics, namely, cosmetic preparations for skin care, cosmetic preparations for body care, cosmetic preparations for bath and shower, cosmetic creams, lotions, and ointments and gels for skin care, cosmetic skin fresheners and toners, cosmetic preparations for the hair and scalp, and hair lotions; Dentifrices, namely, anti-cavity dental rinses, mouth rinses and mouth washes, cosmetic preparations for the care of mouth and teeth
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of alimentary tract and metabolic diseases and disorders, dermatological diseases and disorders, genito-urinary and sexual diseases and disorders, musculo-skeletal system diseases and disorders, nervous system diseases and disorders, respiratory system diseases and disorders, cardio-vascular diseases and disorders specifically excluding tissue plasminogen activators; pharmaceutical preparations for the prevention and treatment of sensory organ diseases and disorders, systemic hormonal pharmaceutical preparations and substances, pharmaceuticals, namely, anti-infectives, pharmaceutical preparations, namely, antineoplastic and immunomodulating agents, antiparasitic preparations and substances; contraceptives; hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing preparations, pharmaceutical preparations and substances for the treatment of premenstrual syndrome, post natal depression, fluctuating hormone levels, pharmaceutical preparations and substances for infertility disorders, pharmaceutical preparations and substances for in vitro fertilization (ivf); pharmaceutical preparations in the nature of medicated dental rinses, mouth rinses, mouthwashes, dental lozenges, dental tablets and medicated chewing gum; dental wax; pharmaceutical preparations in the nature of pregnancy test kits, ovulation test kits and in-vitro ovulation prediction test kits all for home use; pharmaceutical preparations in the nature of diagnostic test kits for home use for detecting urinary tract infections, for detecting menopause, for detecting vaginal pH balances and for detecting sexually-transmitted diseases; pharmaceutical preparations for skin care; all the foregoing specifically excluding tissue plasminogen activators
- Class 041 — Education and entertainment services: Education services, namely, conducting conferences, seminars, webinars, video case studies, classes and workshops in the fields of healthcare, women's health, pharmaceuticals and medicine, pharmaceutical research and development
- Class 042 — Scientific and technological services: Scientific and technological services, namely, consulting in the field of pharmaceuticals pertaining to biotechnology, product evaluation, diagnostics, testing and inspection; pharmaceutical research and development; industrial analysis and research services in the field of pharmaceuticals and chemical analysis
Owner
- ACTAVIS HOLDCO US, INC., PARSIPPANY, NJ, US
- ACTAVIS, INC., PARSIPPANY, NJ, US
- ACTAVIS, INC., PARSIPPANY, NJ, US
- Actavis Group PTC ehf, Hafnarfjordur, IS
Prosecution history
- 12 Feb 2018 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 12 Feb 2018 — ABANDONMENT - NO USE STATEMENT FILED
- 27 Jul 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Jul 2017 — SOU EXTENSION 4 GRANTED
- 07 Jul 2017 — SOU EXTENSION 4 FILED
- 20 Jul 2017 — NOTICE OF REVIVAL - E-MAILED
- 19 Jul 2017 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 19 Jul 2017 — PETITION TO REVIVE-GRANTED
- 19 Jul 2017 — TEAS PETITION TO REVIVE RECEIVED
- 19 Jul 2017 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Feb 2017 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 06 Jan 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Jan 2017 — SOU EXTENSION 3 GRANTED
- 04 Jan 2017 — SOU EXTENSION 3 FILED
- 04 Jan 2017 — SOU TEAS EXTENSION RECEIVED